Compass Therapeutics, Inc. (CMPX)

0.8637 -0.03 (-3.68%) USD  |  NASDAQ  |  Oct 16, 16:00
0.8637 0.00 (0.00%) After-Hours: 20:00
More

Compass Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for CMPX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Operating Expenses (% of Quarterly Revenues) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2024 --

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Viking Therapeutics, Inc. --
Capricor Therapeutics, Inc. --
Ardelyx, Inc. Upgrade
Biomea Fusion, Inc. --
ARS Pharmaceuticals, Inc. Upgrade